{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:49:24Z","timestamp":1770482964936,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T00:00:00Z","timestamp":1360627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00404-013-2748-5","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T06:06:34Z","timestamp":1360562794000},"page":"341-347","source":"Crossref","is-referenced-by-count":19,"title":["Flare up of ulcerative colitis during pregnancy treated by adsorptive granulocyte and monocyte apheresis: therapeutic outcomes in three pregnant patients"],"prefix":"10.1007","volume":"288","author":[{"given":"Hiroki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuaki","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"key":"2748_CR1","first-page":"15","volume-title":"Inflammatory bowel disease","year":"1998","unstructured":"Allison MC, Dhillon AP, Lewis WG (eds) (1998) Inflammatory bowel disease. Londonm, Mosby, pp 15\u201395"},{"key":"2748_CR2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.crohns.2012.04.009","volume":"6","author":"S Vermeire","year":"2012","unstructured":"Vermeire S, Carbonnel F, Coulie PG et al (2012) Management of inflammatory bowel disease in pregnancy. J Crohns Colitis 6:811\u2013823","journal-title":"J Crohns Colitis"},{"key":"2748_CR3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/gut.2005.078097","volume":"55","author":"U Mahadevan","year":"2006","unstructured":"Mahadevan U (2006) Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 55:1198\u20131206","journal-title":"Gut"},{"key":"2748_CR4","first-page":"B4360","volume":"58","author":"BM N\u00f8rg\u00e5rd","year":"2011","unstructured":"N\u00f8rg\u00e5rd BM (2011) Birth outcome in women with ulcerative colitis and Crohn\u2019s disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Dan Med Bull 58:B4360","journal-title":"Dan Med Bull"},{"key":"2748_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gut.52.2.159","volume":"52","author":"E Alstead","year":"2003","unstructured":"Alstead E, Nelson-Piercy C (2003) Inflammatory bowel disease in pregnancy. Gut 52:159\u2013161","journal-title":"Gut"},{"key":"2748_CR6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.2006.108324","volume":"56","author":"J Cornish","year":"2007","unstructured":"Cornish J, Tan E, Teare J et al (2007) A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56:830\u2013837","journal-title":"Gut"},{"key":"2748_CR7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2007.07.019","volume":"133","author":"U Mahadevan","year":"2007","unstructured":"Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA (2007) Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 133:1106\u20131112","journal-title":"Gastroenterology"},{"key":"2748_CR8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1572-0241.2002.05543.x","volume":"97","author":"JA Dominitz","year":"2002","unstructured":"Dominitz JA, Young JC, Boyko EJ (2002) Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 97:641\u2013648","journal-title":"Am J Gastroenterol"},{"key":"2748_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0889-8553(05)70354-X","volume":"27","author":"BI Korelitz","year":"1998","unstructured":"Korelitz BI (1998) Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 27:213\u2013224","journal-title":"Gastroenterol Clin North Am"},{"key":"2748_CR10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0016-5085(81)90193-1","volume":"80","author":"M Mogadam","year":"1981","unstructured":"Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW (1981) Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 80:72\u201376","journal-title":"Gastroenterology"},{"key":"2748_CR11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ibd.21154","volume":"16","author":"JP Gisbert","year":"2010","unstructured":"Gisbert JP (2010) Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. Inflamm Bowel Dis 16:881\u2013895","journal-title":"Inflamm Bowel Dis"},{"key":"2748_CR12","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","volume":"46","author":"SL Brown","year":"2002","unstructured":"Brown SL, Greene MH, Gershon SK, Edwards ET, Mraun MM (2002) Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the food and drug administration. Arthritis Rheum 46:3151\u20133158","journal-title":"Arthritis Rheum"},{"key":"2748_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","volume":"37","author":"AR Saniabadi","year":"2007","unstructured":"Saniabadi AR, Hanai H, Lofberg R et al (2007) Therapeutic leucocytapheresis for inflammatory bowel disease. Transf Aphere Sci 37:191\u2013200","journal-title":"Transf Aphere Sci"},{"key":"2748_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2249.2010.04279.x","volume":"163","author":"H Hanai","year":"2011","unstructured":"Hanai H, Takeda Y, Saniabadi AR et al (2011) The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review. Clin Exp Immunol 163:50\u201358","journal-title":"Clin Exp Immunol"},{"key":"2748_CR15","doi-asserted-by":"crossref","unstructured":"Yamamoto T, Umegae S, Matsumoto K (2012) Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis. J Crohn\u2019s Colitis 6:750\u2013755","DOI":"10.1016\/j.crohns.2011.12.009"},{"issue":"7","key":"2748_CR16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","volume":"2003","author":"AR Saniabadi","year":"2003","unstructured":"Saniabadi AR, Hanai H, Takeuchi K et al (2003) Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory disease associated with leukocytes. Ther Apher Dial 2003(7):48\u201359","journal-title":"Ther Apher Dial"},{"key":"2748_CR17","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/ajg.2009.453","volume":"104","author":"A Sakuraba","year":"2009","unstructured":"Sakuraba A, Motoya S, Watanabe K et al (2009) An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 104:2990\u20132995","journal-title":"Am J Gastroenterol"},{"key":"2748_CR18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","volume":"49","author":"Y Suzuki","year":"2004","unstructured":"Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y (2004) Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid na\u00efve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 49:565\u2013571","journal-title":"Dig Dis Sci"},{"key":"2748_CR19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2004.02288.x","volume":"20","author":"E Domenech","year":"2004","unstructured":"Domenech E, Hinojosa J, Esteve-Comas M (2004) Spanish group for the study of Crohn\u2019s disease and ulcerative colitis (GETECCU). Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther 20:1347\u20131352","journal-title":"Aliment Pharmacol Ther"},{"key":"2748_CR20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.dld.2007.02.003","volume":"39","author":"R Caprilli","year":"2007","unstructured":"Caprilli R, D\u2019Ovidio V (2007) Leukocytapheresis as promising therapy for inflammatory bowel disease. Dig Liver Dis 39:435\u2013437","journal-title":"Dig Liver Dis"},{"key":"2748_CR21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2008.04.023","volume":"135","author":"BE Sands","year":"2008","unstructured":"Sands BE, Sandborn WJ, Feagan B et al (2008) A randomized, double-blind, sham-controlled study of granulocyte\/monocyte apheresis for active ulcerative colitis. Gastroenterology 135:400\u2013409","journal-title":"Gastroenterology"},{"key":"2748_CR22","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","volume":"330","author":"S Lichtiger","year":"1994","unstructured":"Lichtiger S, Present DH, Kornbluth A et al (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841\u20131845","journal-title":"N Engl J Med"},{"key":"2748_CR23","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317:1625\u20131629","journal-title":"N Engl J Med"},{"key":"2748_CR24","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3109\/14767058.2012.684176","volume":"25","author":"G Oron","year":"2012","unstructured":"Oron G, Yogev Y, Shkolnik S et al (2012) Inflammatory bowel disease: risk factors for adverse pregnancy outcome and the impact of maternal weight gain. J Matern Fetal Neonatal Med 25:2256\u20132260","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2748_CR25","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10620-006-9199-9","volume":"51","author":"Y Suzuki","year":"2006","unstructured":"Suzuki Y, Yoshimora N, Saito Y, Saniabadi A (2006) A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci 51:2031\u20132038","journal-title":"Dig Dis Sci"},{"key":"2748_CR26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.dld.2008.02.012","volume":"40","author":"T Tanaka","year":"2008","unstructured":"Tanaka T, Okanobu H, Yoshimi S et al (2008) Adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid na\u00efve patients. Dig Liver Dis 40:731\u2013736","journal-title":"Dig Liver Dis"},{"key":"2748_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","volume":"16","author":"T Shimoyama","year":"2001","unstructured":"Shimoyama T, Sawada K, Hiwatashi N et al (2001) Safety and efficacy of granulocytes and monocyte adsorption apheresis in patients with active ulcerative colitis: a multiple study. J Clin Apher 16:1\u20139","journal-title":"J Clin Apher"},{"key":"2748_CR28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.gcb.2010.08.007","volume":"34","author":"T Tanaka","year":"2010","unstructured":"Tanaka T, Okanobu H, Kuga Y et al (2010) Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: a report based on 120 patients with active ulcerative colitis. Gastroenterol Clin Biol 34:687\u2013695","journal-title":"Gastroenterol Clin Biol"},{"key":"2748_CR29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.crohns.2012.02.005","volume":"6","author":"S Kato","year":"2012","unstructured":"Kato S, Hosomi E, Amano F et al (2012) The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn\u2019s disease complicated by extensive subcutaneous aseptic neutrophilic abscesses. J Crohns Colitis 6:787\u2013791","journal-title":"J Crohns Colitis"},{"key":"2748_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1098-1101(1999)14:1<42::AID-JCA8>3.0.CO;2-2","volume":"14","author":"FJ Strobl","year":"1999","unstructured":"Strobl FJ, Voelkerding KV, Smith EP (1999) Management of chronic myeloid leukemia during pregnancy with leukapheresis. J Clin Apher 14:42\u201344","journal-title":"J Clin Apher"},{"key":"2748_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jjco\/hyh038","volume":"34","author":"R Ali","year":"2004","unstructured":"Ali R, Ozkalemka\u015f F, Ozkocaman V et al (2004) Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature. Jpn J Clin Oncol 34:215\u2013217","journal-title":"Jpn J Clin Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-2748-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-013-2748-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-2748-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:17:06Z","timestamp":1562671026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-013-2748-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,12]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2748"],"URL":"https:\/\/doi.org\/10.1007\/s00404-013-2748-5","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,12]]}}}